When a federal judge in Texas ruled that the Food and Drug administration shouldn't have approved the abortion pill mifepristone in 2000, he agreed with arguments by plaintiffs who oppose abortion rights in ruling that the agency improperly used a process of accelerated approval that didn't fully assess the drug's risks and benefits..
An appeals court stayed the part of the lower court's decision that would have invalidated the FDA approval, but the matter could ultimately be decided by the Supreme Court.
